Abbott Completes Study Enrolment for Heart Rhythm Treatment Device, Launches New Heart Mapping Technology-February 2024-www.financetom.com

Abbott Completes Study Enrolment for Heart Rhythm Treatment Device, Launches New Heart Mapping Technology

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Abbott Completes Study Enrolment for Heart Rhythm Treatment Device, Launches New Heart Mapping Technology

Oct 10, 2024 11:12 PM

10:45 AM EDT, 10/10/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) said Thursday it has completed enrolment of nearly 400 patients in the global investigational device exemption study for its abnormal heart rhythm treatment Volt Pulsed Field Ablation system in three months, which is ahead of schedule.

The global FOCALFLEX trial is also underway to evaluate Abbott's TactiFlex Duo Ablation Catheter, which offers dual-energy ablation for treating paroxysmal atrial fibrillation, the company said.

Abbott also said it has received clearance from the US Food and Drug Administration for its Advisor HD Grid X Mapping Catheter, which will support high-density heart mapping for ablation cases.

Price: 115.92, Change: -0.03, Percent Change: -0.03

Previous page： Acorda Therapeutics Agrees to Sell Substantially All Assets to Germany's Merz Therapeutics for $185 Million Next page： Zhibao Technology Prices IPO at $4 a Share

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Acorda Therapeutics Agrees to Sell Substantially All Assets to Germany's Merz Therapeutics for $185 Million

Apr 2, 2024

04:46 AM EDT, 04/02/2024 (MT Newswires) -- Acorda Therapeutics ( ACOR ) said late Monday it has signed an agreement to sell substantially all its assets to Merz Therapeutics for $185 million. The company said it filed voluntary petitions to start Chapter 11 proceedings in the US Bankruptcy Court for the Southern District of New York to facilitate the sale...

Zhibao Technology Prices IPO at $4 a Share

Apr 2, 2024

04:33 AM EDT, 04/02/2024 (MT Newswires) -- Zhibao Technology said late Monday it priced its initial public offering of 1.5 million class A ordinary shares at $4 per share. Underwriters have been granted a 45-day option to purchase up to 225,000 additional shares to cover over-allotments. Shares are expected to debut on the Nasdaq Capital Market this Tuesday under the...

Tesla's China-made EV sales edge up 0.2% y/y in March

Apr 2, 2024

BEIJING (Reuters) - U.S. automaker Tesla sold 89,064 China-made electric vehicles in March, a 0.2% increase from a year earlier, China Passenger Car Association (CPCA) data showed on Tuesday. Deliveries of China-made Model 3 and Model Y vehicles were up 47.5% from February. Chinese rival BYD, with its Dynasty and Ocean series of EVs and plug-in hybrids, sold 302,459 vehicles...

Madison Square Garden Sports Chief Operating Officer Departs

Apr 2, 2024

04:52 AM EDT, 04/02/2024 (MT Newswires) -- Madison Square Garden Sports ( MSGS ) said in a Monday regulatory filing that President and Chief Operating Officer David Hopkinson departed the company, effective April 1. The company did not name a successor to Hopkinson in the filing. Price: 183.5, Change: -0.11, Percent Change: -0.06 ...